EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 62017TJ0103
Judgment of the General Court (Fourth Chamber) of 9 March 2018.#Recordati Orphan Drugs v European Union Intellectual Property Office.#EU trade mark — Opposition proceedings — Application for EU word mark NORMOSANG — Earlier national word mark NORMON — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001) — Rule 19(2)(a)(ii) and Rule 20(1) of Regulation (EC) No 2868/95 (now Article 7(2)(a)(ii) and Article 8(1) and (7) of Delegated Regulation (EU) 2017/1430).#Case T-103/17.
Judgment of the General Court (Fourth Chamber) of 9 March 2018.
Recordati Orphan Drugs v European Union Intellectual Property Office.
EU trade mark — Opposition proceedings — Application for EU word mark NORMOSANG — Earlier national word mark NORMON — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001) — Rule 19(2)(a)(ii) and Rule 20(1) of Regulation (EC) No 2868/95 (now Article 7(2)(a)(ii) and Article 8(1) and (7) of Delegated Regulation (EU) 2017/1430).
Case T-103/17.
Judgment of the General Court (Fourth Chamber) of 9 March 2018.
Recordati Orphan Drugs v European Union Intellectual Property Office.
EU trade mark — Opposition proceedings — Application for EU word mark NORMOSANG — Earlier national word mark NORMON — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001) — Rule 19(2)(a)(ii) and Rule 20(1) of Regulation (EC) No 2868/95 (now Article 7(2)(a)(ii) and Article 8(1) and (7) of Delegated Regulation (EU) 2017/1430).
Case T-103/17.
ECLI identifier: ECLI:EU:T:2018:126